These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 30135690)

  • 1. Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases.
    Dobó J; Kocsis A; Gál P
    Front Immunol; 2018; 9():1851. PubMed ID: 30135690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential Roles for Mannose-Binding Lectin-Associated Serine Protease-1/3 in the Development of Lupus-Like Glomerulonephritis in MRL/
    Machida T; Sakamoto N; Ishida Y; Takahashi M; Fujita T; Sekine H
    Front Immunol; 2018; 9():1191. PubMed ID: 29892304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems.
    Dobó J; Kocsis A; Farkas B; Demeter F; Cervenak L; Gál P
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging roles of mannose-binding lectin-associated serine proteases (MASPs) in the lectin pathway of complement and beyond.
    Dobó J; Pál G; Cervenak L; Gál P
    Immunol Rev; 2016 Nov; 274(1):98-111. PubMed ID: 27782318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key Components of the Complement Lectin Pathway Are Not Only Required for the Development of Inflammatory Arthritis but Also Regulate the Transcription of Factor D.
    Holers VM; Borodovsky A; Scheinman RI; Ho N; Ramirez JR; Dobó J; Gál P; Lindenberger J; Hansen AG; Desai D; Pihl R; Thiel S; Banda NK
    Front Immunol; 2020; 11():201. PubMed ID: 32153567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting Edge: Role of MASP-3 in the Physiological Activation of Factor D of the Alternative Complement Pathway.
    Hayashi M; Machida T; Ishida Y; Ogata Y; Omori T; Takasumi M; Endo Y; Suzuki T; Sekimata M; Homma Y; Ikawa M; Ohira H; Fujita T; Sekine H
    J Immunol; 2019 Sep; 203(6):1411-1416. PubMed ID: 31399515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process.
    Hamad I; Hunter AC; Szebeni J; Moghimi SM
    Mol Immunol; 2008 Dec; 46(2):225-32. PubMed ID: 18849076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked.
    Dobó J; Szakács D; Oroszlán G; Kortvely E; Kiss B; Boros E; Szász R; Závodszky P; Gál P; Pál G
    Sci Rep; 2016 Aug; 6():31877. PubMed ID: 27535802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor D.
    Sekine H; Machida T; Fujita T
    Immunol Rev; 2023 Jan; 313(1):15-24. PubMed ID: 36316810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern-recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44.
    Degn SE; Jensen L; Olszowski T; Jensenius JC; Thiel S
    J Immunol; 2013 Aug; 191(3):1334-45. PubMed ID: 23785123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complex formation of MASP-3 with pattern recognition molecules of the lectin complement pathway retains MASP-3 in the circulation.
    Kusakari K; Machida T; Ishida Y; Omori T; Suzuki T; Sekimata M; Wada I; Fujita T; Sekine H
    Front Immunol; 2022; 13():907023. PubMed ID: 36052069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional overview of the lectin complement pathway: its molecular basis and physiological implication.
    Matsushita M; Endo Y; Fujita T
    Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):273-83. PubMed ID: 23563865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting Edge: A New Player in the Alternative Complement Pathway, MASP-1 Is Essential for LPS-Induced, but Not for Zymosan-Induced, Alternative Pathway Activation.
    Paréj K; Kocsis A; Enyingi C; Dani R; Oroszlán G; Beinrohr L; Dobó J; Závodszky P; Pál G; Gál P
    J Immunol; 2018 Apr; 200(7):2247-2252. PubMed ID: 29475986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of MASP-1/3 in complement activation.
    Sekine H; Takahashi M; Iwaki D; Fujita T
    Adv Exp Med Biol; 2013; 735():41-53. PubMed ID: 23402018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes.
    Schwaeble W; Dahl MR; Thiel S; Stover C; Jensenius JC
    Immunobiology; 2002 Sep; 205(4-5):455-66. PubMed ID: 12396007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
    Yuan X; Gavriilaki E; Thanassi JA; Yang G; Baines AC; Podos SD; Huang Y; Huang M; Brodsky RA
    Haematologica; 2017 Mar; 102(3):466-475. PubMed ID: 27810992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deconstructing the Lectin Pathway in the Pathogenesis of Experimental Inflammatory Arthritis: Essential Role of the Lectin Ficolin B and Mannose-Binding Protein-Associated Serine Protease 2.
    Banda NK; Acharya S; Scheinman RI; Mehta G; Takahashi M; Endo Y; Zhou W; Farrar CA; Sacks SH; Fujita T; Sekine H; Holers VM
    J Immunol; 2017 Sep; 199(5):1835-1845. PubMed ID: 28739878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A journey through the lectin pathway of complement-MBL and beyond.
    Garred P; Genster N; Pilely K; Bayarri-Olmos R; Rosbjerg A; Ma YJ; Skjoedt MO
    Immunol Rev; 2016 Nov; 274(1):74-97. PubMed ID: 27782323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway.
    Takahashi M; Iwaki D; Kanno K; Ishida Y; Xiong J; Matsushita M; Endo Y; Miura S; Ishii N; Sugamura K; Fujita T
    J Immunol; 2008 May; 180(9):6132-8. PubMed ID: 18424734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway.
    Iwaki D; Kanno K; Takahashi M; Endo Y; Matsushita M; Fujita T
    J Immunol; 2011 Oct; 187(7):3751-8. PubMed ID: 21865552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.